Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocotrienols in Parkinson's Disease
NCT04491383Phase 2Active, not recruiting
- Sponsor
- National Neuroscience Institute
- Start
- Apr 2021
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of tocovid in Parkinson's disease (PD), sponsored by National Neuroscience Institute. Started Apr 2021; status: active, not recruiting.
02
Drugs
tocovid
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04491383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04491383.